老年退伍军人PTSD合并痴呆者第二代抗精神病药超说明书处方更多
该研究基于2003—2010年退伍军人健康管理局数据,纳入93,068名65岁以上PTSD退伍军人(11.1%合并痴呆),分析第二代抗精神病药(SGA)处方趋势。结果显示2004—2009年SGA处方率总体下降(无痴呆者7.0%降至5.1%,合并痴呆者13.2%降至8.9%),但合并痴呆者接受SGA的比值比始终至少为无痴呆者的两倍(OR 2.03–2.33)。
要点
- PTSD合并痴呆的老年退伍军人接受SGA的几率是无痴呆者的2倍以上。
- 2004—2009年SGA处方率在两组中均逐年下降,但合并痴呆组始终更高。
- SGA在该人群缺乏确切疗效证据,且共病多,超说明书使用需谨慎。
核心结论
- 尽管老年PTSD退伍军人的SGA处方减少,但合并痴呆者处方SGA的几率始终高于单纯PTSD者。
- 鉴于该人群共病率高且SGA治疗痴呆缺乏有力疗效证据,这一处方现象值得关注。
研究设计与样本
- 全国系列横断面研究,数据来自退伍军人健康管理局2003—2010年住院和门诊记录。
- 纳入93,068名65岁及以上PTSD退伍军人(排除精神分裂症或双相障碍),其中11.1%合并痴呆。
主要发现
- 2004—2009年,无痴呆的PTSD退伍军人SGA处方率从7.0%降至5.1%,合并痴呆者从13.2%降至8.9%。
- 多因素logistic回归显示,合并痴呆者接受SGA的比值比(OR)为2.03(95%CI 1.82–2.26)至2.33(95%CI 2.10–2.58)。
关键数值与推荐
- 合并痴呆的PTSD退伍军人接受SGA的OR至少为2.03(95%CI 1.82–2.26),最高达2.33(95%CI 2.10–2.58)。
临床怎么用
- 对PTSD合并痴呆的老年患者处方SGA前,应审慎评估获益与风险,优先考虑非药物干预。
- 需关注SGA超说明书使用在该人群中的持续高发现象,定期复核用药指征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine whether elderly veterans with posttraumatic stress disorder (PTSD) and dementia are more likely to be prescribed second-generation antipsychotics (SGAs) than those with PTSD alone. DESIGN: National serial cross-sectional study. SETTING: Veterans Health Affairs inpatient and outpatient settings. PARTICIPANTS: Veterans aged 65 and older with PTSD (excluding schizophrenia or bipolar disorder) with or without concomitant dementia who received care from the Veterans Health Administration between 2003 and 2010 were identified using International Classification of Diseases, Ninth Revision, codes (N = 93,068; 11.1% with dementia). MEASUREMENTS: Trends in SGA prescribing and odds of being prescribed an SGA were determined using a multivariable logistic regression model adjusted for clinical, sociodemographic, and geographic covariates. RESULTS: Between 2004 and 2009, SGA prescribing declined annually from 7.0% to 5.1% of elderly veterans with PTSD without dementia and 13.2% to 8.9% in those with dementia; findings over time consistently indicated that veterans with PTSD and dementia had at least twice the odds of being prescribed an SGA as those without PTSD (odds ratios 2.03 (95% confidence interval (CI) = 1.82-2.26) to 2.33 (95% CI = 2.10-2.58). CONCLUSION: Although the prescribing of SGAs to elderly veterans with PTSD has decreased, prescribing an SGA to those with dementia remained consistently higher than for those with PTSD alone and is problematic given the high prevalence of medical comorbidities in this aging population coupled with the lack of compelling evidence for effectiveness of SGAs in individuals with dementia.
引用
- Semla TP, Lee A, Gurrera R, et al. Off-Label Prescribing of Second-Generation Antipsychotics to Elderly Veterans with Posttraumatic Stress Disorder and Dementia. J Am Geriatr Soc. 2017. PMID: 28369688. doi:10.1111/jgs.14897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。